Nav: Home

Cancer cell collaborators smooth the way for cancer cells to metastasize

December 13, 2015

At ASCB 2015, Vanderbilt researchers show how metastasizing tumors use non-cancerous fibroblasts to make a migration highway through surrounding extracellular matrix.

To get moving, metastasizing cancer needs to enlist non-cancerous collaborators. Suspicions about where these secret cancer allies might be lurking have long been directed at the fibroblasts, the cells that secrete and organize the extracellular matrix (ECM), the ground on which surrounding cells can get a grip. Increasing evidence suggests that fibroblasts near growing tumors are actively assisting cancer cells in spreading locally and metastasizing elsewhere. But exactly how these cancer-associated fibroblasts (CAFs) provide aid to the cancer enemy was not known until a recent discovery by Begum Erdogan and colleagues in Donna Webb's lab at Vanderbilt University--CAFs clear a highway through the ECM for migrating cancer cells. The researchers will present their work at ASCB 2015 in San Diego on Sunday, December 13 and Tuesday, December 15.

The roadway that CAFs arrange is made of parallel fibers of fibronectin (Fn), a major protein in the ECM mix secreted by all fibroblasts. The Vanderbilt researchers observed CAFs rearranging Fn into parallel bundles instead of the dense mesh that normal tissue fibroblasts (NAFs) make. Taking cancer cells grown from prostate as well as head and neck tumors, the researchers plated them on ECM from CAFs and NAFs. The cancer cells on the CAF matrix were better at moving in a single direction.

But why? CAFs rearrange the matrix into a road because they get a better grip on Fn fibers, the researchers discovered. Using traction force microscopy, they were able to measure the difference. CAFs were stronger than NAFs because they were better at delivering force from the motor protein, myosin II, through connectors called integrins to Fn fibers. CAFs had higher levels of a Fn-binding integrin plus a switched-on GTPase called Rac, which is critical to cell movement. Inhibiting myosin-II activity with a drug deprived CAFs of their super traction powers and the ECM reverted to its normal disorder. These results solve a longstanding puzzle about cancer metastasis and point to the matrix as a possible target for drugs to stop cancer in its tracks.
-end-
Cancer-associated fibroblasts promote directional migration of cancer cells via parallel organization of the fibronectin matrix
B. Erdogan1, M. Ao1, B.M. Brewer2, O.E. Franco3,4,5, S.W. Hayward3,4,5, D. Li2, D.J. Webb1,3
1Biological Sciences, Vanderbilt University, Nashville, TN, 2Mechanical Engineering, Vanderbilt University, Nashville, TN, 3Cancer Biology, Vanderbilt University, Nashville, TN, 4Urologic Surgery, Vanderbilt University, Nashville, TN, 5Surgery, NorthShore University HealthSystem, Evanston, IL

Contact author: Begum Erdogan
begum.erdogan@Vanderbilt.Edu
Lab (615) 343-9031

At ASCB 2015
Author presents:
Microsymposium 01: Cell Motility & Migration
Sunday, December 13
12:05-12:10 pm
Microsymposia Room 1

Integrins & Cell-ECM Interactions
Tuesday, December 15
1:30-3:00 pm
P2225
Board Number: B1356
ASCB Learning Center

For ASCB, contact: John Fleischman
jfleischman@ascb.org

Video available: "JHUcells on CAF-CDM" https://vimeo.com/147615483
Caption for video: Red labeled JHU12 head and neck carcinoma cells are migrating on CAF-derived extracellular matrix (green). Images were taken every 10 minutes for 3 hours using a confocal microscope.

American Society for Cell Biology

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#555 Coronavirus
It's everywhere, and it felt disingenuous for us here at Science for the People to avoid it, so here is our episode on Coronavirus. It's ok to give this one a skip if this isn't what you want to listen to right now. Check out the links below for other great podcasts mentioned in the intro. Host Rachelle Saunders gets us up to date on what the Coronavirus is, how it spreads, and what we know and don't know with Dr Jason Kindrachuk, Assistant Professor in the Department of Medical Microbiology and infectious diseases at the University of Manitoba. And...
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at Radiolab.org/donate.